Could novel immune cell therapy combat hepatitis B infections?
Chronic infection with the hepatitis B virus (HBV) causes progressive liver problems, and eradication of the virus remains a formidable challenge.
Apr 10, 2024
0
0
Chronic infection with the hepatitis B virus (HBV) causes progressive liver problems, and eradication of the virus remains a formidable challenge.
Apr 10, 2024
0
0
Morphine and other opioids are vital to treat severe and chronic pain. However, they have two problems—prolonged use creates morphine tolerance, where ever-increasing doses are needed for the same pain relief, and paradoxically, ...
Apr 9, 2024
0
53
New findings from Cleveland Clinic and Tufts University researchers show high blood levels of TMAO (trimethylamine N-oxide) predict future risk of developing chronic kidney disease over time.
Apr 9, 2024
0
0
From 2020 to 2022, there was an increase in enrollment in medical cannabis programs but a decrease in jurisdictions with nonmedical adult-use laws, according to a study published online April 9 in the Annals of Internal Medicine.
Apr 9, 2024
0
0
A new Society of Radiologists in Ultrasound (SRU) expert consensus statement to improve endometriosis evaluation was published in the journal Radiology.
Apr 9, 2024
0
0
No therapies currently exist that can halt the progression of chronic kidney disease in children or restore the ability of kidney cells to filter blood. Recently, researchers at the GOFARR Laboratory for Organ Regenerative ...
Apr 8, 2024
0
0
While the composite of death and heart failure hospitalizations was not significantly reduced, empagliflozin may help reduce heart failure risks after a heart attack
Apr 8, 2024
0
0
A new study exploring the use of repeat antibiotic prescriptions for the same respiratory tract infection (RTI) episode—known as repeat 'within-episode' prescriptions—in primary care has found high rates of their use ...
Apr 8, 2024
0
0
Chronic kidney disease patients living in the hottest countries experienced an additional 8% drop in kidney function each year compared to those living in temperate climates, finds a new study from researchers at UCL and ...
Apr 8, 2024
0
84
A new meta-analysis shows sodium glucose co-transporter 2 (SGLT2) inhibitors reduce the risk of major adverse cardiovascular events in patients with either diabetes at high risk of atherosclerotic cardiovascular disease (ASCVD), ...
Apr 8, 2024
0
0